Walleye Capital LLC Viatris Inc Put Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $933,960 - $1.1 Million	90,500 Added 137.33%	156,400 $1.82 Million
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $106,530 - $127,412	-10,600 Reduced 13.86%	65,900 $700,000
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $289,639 - $347,721	25,700 Added 50.59%	76,500 $913,000
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $46,481 - $57,505	5,300 Added 11.65%	50,800 $550,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $218,652 - $258,780	22,800 Added 100.44%	45,500 $448,000
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $204,754 - $233,582	22,700 New	22,700 $226,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.